Skip to main content
. 2016 Jun 13;13:100. doi: 10.1186/s12985-016-0555-x

Table 2.

Key clinical signs and treatment during an experiment with BCoV infected calves

Animal group Calf no. Peak rta (°C) Number of days with Peak clinical score Days with clinical score >6 Day of treatment initiationd
depression diarrheab nasal dischargec respiratory rate ≥65
Field F1 40,3 0 3 1 0 5 0 −1
F2 39,8 3 2 1 0 8 2 3
F3 40,1 2 0 7 0 7 1 −5e
F4 40,6 1 0 4 1 7 2 2
F5 39,7 2 13 1 2 6 0 -
F6 39,2 1 0 4 0 5 0 -
Exposed E1 39,5 7 0 2 3 7 1 -
E2 39,8 4 1 7 1 8 3 7
E3 40,2 8 1 19 2 9 5 5 and 18
E4 39,9 6 1 8 0 8 4 -
Sentinel S1 39,2 1 4 3 0 5 0 -
S2 39,4 2 0 3 0 4 0 -

The calves were exposed to BCoV in the field (F1-6), were exposed to F-animals (E1-4) or exposed to E-animals (S1-2). aPeak rectal temperature (rt) bRunny to watery stools were considered diarrheic. c Mucopurulent or purulent nasal discharge (nasal discharge score =2). d Five days of i.m. treatment with 30 000 IU procaine benzylpenicillin was initiated on indicated day. e Calf F3 was treated for six days